John M. Sprague, Chief Financial Officer at T2 Biosystems, Inc. (TTOO), sold 5,250 shares at $2.04 ($11K) on 2021-02-23, disclosed to the SEC on 2021-02-23.
Scheduled sale ($11k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TTOO | SELL | 2020-03-03 | $3K | — | Filing → |